Symmetry Medical Inc. Updates 2006 Second Quarter Revenue Estimate

WARSAW, Ind., June 19 /PRNewswire-FirstCall/ -- Symmetry Medical, Inc. , an independent provider of products to the global orthopedic device industry, announced today that it is updating its revenue estimate for the second quarter of 2006. During its first quarter investor conference call in May 2006, the Company indicated that it expected second quarter revenues to be "similar" to first quarter revenues of $69.6 million. Symmetry now expects revenues for the second quarter 2006 to be in the range of $63 to $65 million.

Brian Moore, President and Chief Executive Officer of Symmetry Medical said, "As we indicated when reporting our first quarter 2006 financial results, the orthopedic industry is experiencing a shift from traditional order patterns. While the first half has proven to be somewhat softer than we expected, the orthopedic industry is still considered to be back-end loaded this year. We remain cautiously optimistic for the remainder of the year and expect that we will be in a position to provide greater clarity on the remainder of the year at the time we report second quarter results."

About Symmetry Medical Inc.

Symmetry Medical Inc. is an independent provider of implants and related instruments and cases to the orthopedic device industry. The Company also designs, develops and produces these products for companies in other segments of the medical device market, including dental, osteobiologic and endoscopy sectors and provides limited specialized products and services to non- healthcare markets, such as the aerospace market.

Forward Looking Statements

Statements in the press release regarding Symmetry Medical Inc.'s business, which are not historical facts, may be "forward-looking statements" that involve risks and uncertainties, within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are predictive in nature and are frequently identified by the use of terms such as "may," "will," "should," "expect," "believe," "estimate," "intend," and similar words indicating possible future expectations, events or actions. Such predictive statements are not guarantees of future performance, and actual results could differ materially from our current expectations. Certain factors that could cause actual results to differ include: the loss of one or more customers; the development of new products or product innovations by our competitors; product liability; changes in management; changes in conditions effecting the economy, orthopedic device manufacturers or the medical device industry generally; and changes in government regulation of medical devices and third-party reimbursement practices. We refer you to the "Risk Factors" and "Forward Looking Statements" sections in the Company's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission, which are available on the SEC's Web site at www.sec.gov.

Investors/Media: The Ruth Group Stephanie Carrington/Jason Rando 646-536-7017/7025 scarrington@theruthgroup.comjrando@theruthgroup.com Contact: Symmetry Medical Inc. Andrew Miclot Senior Vice President Marketing, Sales & Business Development Investor Relations Officer 574-269-7390 ext 1002

Symmetry Medical, Inc.

CONTACT: Investors: The Ruth Group, Stephanie Carrington, +1-646-536-7017,scarrington@theruthgroup.com, Media: Jason Rando, +1-646-536-7025,jrando@theruthgroup.com; Symmetry Medical Inc., Andrew Miclot, Senior VicePresident, Marketing, Sales & Business Development, Investor RelationsOfficer, +1-574-269-7390 ext 1002

Back to news